Abstract
Purpose: To determine changes in production of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the ciliary body, the trabecular meshwork and the retinal pigment epithelium induced by both prostaglandins and corticosteroids.
Methods: Explant organ cultures were removed by a scleral incision 3 mm posterior to the limbus. Retinal pigment epithelium was grown to confluence. Organ and cell cultures were treated with latanoprost and/or dexamethasone for 72 h. The activity of MMP- 2, -3 and -9 was assessed using zymography. The synthesis pattern of MMPs and TIMP-1 and -2 was identified using immunostaining.
Results: Treatment of explant organ cultures with 10 μg/ml of latanoprost induced a mean upregulation of MMP-2 by 36%, MMP-3 by 112% and MMP-9 by 156% as seen by zymography. Dexamethasone 500 nm reduced the amounts of secreted MMP-2 by 13%, MMP-3 by 69%. MMP-9 was not detectable in the media of corticosteroid-treated explant organ cultures. The addition of 10 fLg/ml of latanoprost to dexamethasone-treated cultures increased MMP-2 by 14%, MMP-3 by 43% and MMP-9 by 49%. Using immunohistochemistry we found staining with antibodies against MMP-2, -3, -9 and TIMP-1 and -2 within the ciliary body, and only to a lesser degree in the trabecular meshwork. Latanoprost treatment caused an increase of 29% in MMP-2 (p < 0.0001), 98% in MMP-3 (p < 0.0001) and 108% in MMP-9 (p < 0.0001). Dexamethasone reduced the staining for MMP-2 by 32% (p < 0.0001), for MMP-3 by 33% (p < 0.0001) and for MMP-9 by 83% (p < 0.0001). Almost no
change in staining for MMPs was detectable in the trabecular meshwork. Neither latanoprost treatment nor dexamethasone induced significant changes (p < 0.93) in the secretion of TIMPs. In the media of non-treated retinal pigment epithelium (RPE) cells the only MMP detected was MMP-2. RPE cells in culture did not respond to either treatment with a change in their MMP secretion. Conclusion We detected a profound upregulation of both MMP-3 and MMP-9 and a mild induction of MMP-2 through latanoprost in the ciliary body, but not the trabecular meshwork or RPE cells. Corticosteroids, on the other hand, downregulated MMP expression in both tissues. This inhibiting effect of corticosteroids on MMP production was reversed by latanoprost.
Similar content being viewed by others
Article PDF
References
Camras CB, Aim A . Initial clinical studies with prostaglandins and their analogues. Surv Ophthalmol 1997;41(Suppl 2); S61–8.
Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN . Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci 1997;38:2214–23.
Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD . Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1997;38:2772–80.
Ocklind A . Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res 1998;67:179–91.
Krauss AH, Wiederholt M, Sturm A, Woodward DF . Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp Eye Res 1997;64:447–53.
Hoyng PFJ, Rulo A, Greve E, Watson P, Aim A . The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. Surv Ophthalmol 1997;41 (Suppl 2):S93–8.
Anthony TL, Pierce KL, Stamer WP, Regan JW . Prostaglandin F20 < receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci 1998;39:315–21.
Samples JR, Alexander JP, Acott TS . Regulation of levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 1993;34:3386–95.
Rohen JW, Linner E, Witmer R . Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid glaucoma. Exp Eye Res 1973;17:19–31.
Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen Drecoll E . Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997;115:375–83.
Roll P, O Benedikt . Elektronenoptische Untersuchung des Trabekelwerkes beim Kortikosteroidglaukom. Klin Monatsbl Augenheilkd 1979;174:421–8.
Lindsey JD, To HD, Weinreb RN . Induction of c-fos by prostaglandin F2 alpha in human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1994;35:242–50.
Ocklind A, Lake S, Wentzel P, Nister M, Stjernschantz J . Localisation of prostaglandin F2o receptor messenger RNA and protein in the cynomolgus monkey eye. Invest Ophthalmol Vis Sci 1996;37:716–26.
Padgett LC, Lui GM, Werb Z, Lavail MM . Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Exp Eye Res 1997;64:927–38.
Rowe JA, Hattenhauer MG, Herman DC . Adverse side effects associated with latanoprost. Am J Ophthalmol 1997;124:683–5.
Warwar RE, Bullock JD, Ballal D . Cystoid macula edema and anterior uveitis associated with latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998;105:263–8.
Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A . Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998;39:2194–200.
Acott TS, Kingsley PD, Samples JR, Van Buskirk EM . Human trabecular meshwork organ culture: morphology and glycosaminglycan synthesis. Invest Ophthalmol Vis Sci 1988;29:90–100.
Baumgartner J, Huber-Spitzy V, Grabner G, Mayr WR . HLA typing from human donor eyes. Graefes Arch Clin Exp Ophthalmol 1989;227:541–3.
Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA . Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res 1996;62:481–90.
Ando H, Twining SS, Yue BJYT, Zhou X, Fini ME, Kaiya T, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci 1993;34:3541–8.
Hsu SM, Raine L, Fanger H . Use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. J Histochem Cytochem 1981;29:577–80.
Tang S, Scheiffarth OF, Stefani FH . Clinical and immunohistochemical correlations of herpetic keratitis with the expression of HLA-DR antigen. Graefes Arch Clin Exp Ophthalmol 1993;231:162–5.
Patelska B, Greenfield DS, Liebmann JM, Wand M, Kushnick H, Ritch R . Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol 1997;124:279–86.
Alm A, Camras CB, Watson PG . Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv Ophthalmol 1997;41 (Suppl 2):S105–10.
Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998;39:2649–58.
Helm CJ, Holland GN . The effects of posterior sub-Tenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55–64.
Tripathi RC, Kirschner BS, Kipp M, Tripathi BJ, Slotwiner D, Borisuth NS, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology 1992;102:1957–61.
Synder RW, Stamer WD, Kramer TR, Seftor REP . Corticosteroid treatment and trabecular meshwork proteinases in cell and organ culture supernatants. Exp Eye Res 1993;57:461–8.
Matsubara M, Zieski JD, Fini ME . Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991;32:3221–37.
Gaton DD, Sagra T, Lindsey JD, Weinberg RN . Matrix metalloproteinase-1 localisation in the normal uveoscleral outflow pathway. Invest Ophthalmol Vis Sci 1999;40:363–9.
Di-Girolamo N, Verma MJ, McCluskey PJ, Lloyd A, Wakefield D . Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res 1996;15:1060–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Shabrawi, Y., Eckhardt, M., Berghold, A. et al. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye 14, 375–383 (2000). https://doi.org/10.1038/eye.2000.92
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.92
Keywords
This article is cited by
-
Suppression of trabecular meshwork phagocytosis by norepinephrine is associated with nocturnal increase in intraocular pressure in mice
Communications Biology (2022)
-
Diverse effects of pan-ROCK and ROCK2 inhibitors on 2 D and 3D cultured human trabecular meshwork (HTM) cells treated with TGFβ2
Scientific Reports (2021)
-
Establishment of appropriate glaucoma models using dexamethasone or TGFβ2 treated three-dimension (3D) cultured human trabecular meshwork (HTM) cells
Scientific Reports (2021)
-
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases
BMC Ophthalmology (2016)
-
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Biological Research (2014)